Skip to content
Twitter page opens in new windowLinkedin page opens in new windowInstagram page opens in new window
info@pharmaust.com+61 8 9202 6814
PharmAust (PAA)
PharmAust (PAA)
  • HOME
  • ABOUT
    • Company Overview
    • PharmAust Management
    • Epichem Management (OHD)
    • Board
    • Corporate Directory
  • PIPELINE & TRIALS
    • Therapeutic Pipeline
    • MPL Veterinary Trial Details
    • MPL and Veterinary Trials
    • Veterinary Trial Testimonials
    • MPL and Human Trials
    • Publications
    • Pet Cancer Information Service
  • INVESTOR CENTRE
    • News & Announcements
    • Company Research
    • Financial Reports
    • Annual Reports
    • Investor Presentations
    • Corporate Governance
    • Top 20 Shareholders
  • MEDIA
    • BB PAA Video – September 2021
    • OHD Benchtop Flow Reactor Launch
    • Dr Richard Mollard – Full Interview Ticker TV – 17th June 2020
    • Interview with TechInvest – May 2020
    • Dr. Richard Mollard – 6IX Interview March 2020
    • PharmAust In the News
    • PharmAust Videos
    • PharmAust New Cancer Treatment
    • PharmAust and Catalent Commence GMP Tablet Manufacture (Audio)
    • PharmAust on Youtube
  • CONTACT
  • HOME
  • ABOUT
    • Company Overview
    • PharmAust Management
    • Epichem Management (OHD)
    • Board
    • Corporate Directory
  • PIPELINE & TRIALS
    • Therapeutic Pipeline
    • MPL Veterinary Trial Details
    • MPL and Veterinary Trials
    • Veterinary Trial Testimonials
    • MPL and Human Trials
    • Publications
    • Pet Cancer Information Service
  • INVESTOR CENTRE
    • News & Announcements
    • Company Research
    • Financial Reports
    • Annual Reports
    • Investor Presentations
    • Corporate Governance
    • Top 20 Shareholders
  • MEDIA
    • BB PAA Video – September 2021
    • OHD Benchtop Flow Reactor Launch
    • Dr Richard Mollard – Full Interview Ticker TV – 17th June 2020
    • Interview with TechInvest – May 2020
    • Dr. Richard Mollard – 6IX Interview March 2020
    • PharmAust In the News
    • PharmAust Videos
    • PharmAust New Cancer Treatment
    • PharmAust and Catalent Commence GMP Tablet Manufacture (Audio)
    • PharmAust on Youtube
  • CONTACT

Investor Presentations

  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015

Epichem Corporate Presentation July 2020

Investor Presentations 2020By PharmAustJuly 2, 2020

Epichem Pty Ltd Corporate Presentation 2020 Final

Read more

PharmAust Shareholder Update Presentation June 2020

Investor Presentations 2020By PharmAustJuly 2, 2020

PAA PRESENTATION JUN 2020 RA FINAL (1)

Read more

Pitt Street Research Life Science Conference: Investor Presentation

Investor Presentations 2019, News & Announcements 2019By Richard MollardNovember 28, 2019

191128_Investor Presentation

Read more

Investor Roadshow Presentation September 2019

Investor Presentations 2019, News & Announcements 2019By Richard MollardSeptember 9, 2019

190909_Investor Roadshow Presentation September 2019

Read more

July 25 Investor Presentation

Investor Presentations 2019, News & Announcements 2019By Richard MollardJuly 26, 2019

190725_PAA PRESENTATION 25 JULY 2019

Read more

Investor Presentation (August)

August 31, 2017

Investor Presentation (May)

May 10, 2017

PharmAust AGM presentation

November 10, 2016

PharmAust Investor Presentation – June 2016

August 10, 2016

USA Roadshow Presentation – January 2016

January 15, 2016

PharmAust AGM Presentation 2015

October 27, 2015

EGM Shareholder Presentation

May 26, 2015

PharmAust Shareholder Presentation – March 2015

March 15, 2015
MENU
  • Home
  • About Us
  • Pipeline & Trials
  • Investor Centre
  • Media
  • Contact Us
SUBSCRIBE TO OUR NEWSLETTER

TWITTER

PharmAustFollow

PharmAust is a clinical-stage biotech company developing drug discovery IP to treat cancer, viral and neurological diseases. ASX: $PAA FSE: $ECQ

PharmAust
PharmAustPharmAust@PharmAust·
18 Nov

$PAA/@PharmAust has signed agreements with NZ-based Veterinary Specialists Auckland and Intuit Regulatory, to expand its canine Phase 2b lymphoma studies into the country ahead of the upcoming Phase 3 trial.

https://stockhead.com.au/health/pharmaust-expands-studies-in-nz-one-step-closer-towards-a-phase-3-trial-for-canine-cancer/

Reply on Twitter 1461470526476455941Retweet on Twitter 14614705264764559413Like on Twitter 146147052647645594110Twitter 1461470526476455941
Load More...
Copyright © 2020 Pharmaust. All rights reserved.

Website Design & Digital Marketing Perth by Total Click Solutions

Go to Top